Goldman Myla Lai
CIK: 0001168581
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
West Pharmaceutical Services noted in analyst upgrade and market rally. West Pharmaceutical Services has risen about 36% year-to-date, drawing attention in recent market round-ups. TD Cowen kept its positive stance and lifted its price target to $420, citing the company's performance. The stock also appeared in CNBC’s final‑trade segment and in a dividend‑growth stock list, highlighting investor interest.
Transaction History
| QTRX | ▲ Buy | Option Exercise | 8,073 | — | 7/8/2026 | View on chart |
| WST | ▲ Buy | Grant | 791 | $0 | 5/4/2026 | View on chart |
| QTRX | ▲ Buy | Grant | 23,372 | $0 | 1/2/2026 | View on chart |
| QTRX | ▲ Buy | Grant | 1,944 | $0 | 1/2/2026 | View on chart |
| QTRX | ▲ Buy | Grant | 2,084 | $12K | 10/1/2025 | View on chart |
| QTRX | ▲ Buy | Grant | 24,464 | $0 | 7/8/2025 | View on chart |
| QTRX | ▲ Buy | Grant | 2,940 | — | 7/8/2025 | View on chart |
| WST | ▲ Buy | Grant | 1,071 | $0 | 5/6/2025 | View on chart |
| WST | ▲ Buy | Grant | 564 | $0 | 4/23/2024 | View on chart |
| WST | ▲ Buy | Grant | 616 | — | 4/25/2023 | View on chart |
| WST | ▲ Buy | Grant | 632 | — | 5/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Quanterix Highlights Spatial Biology Innovation at ESSB 2026
Quanterix announced it met its spatial biology content innovation commitments during the ESSB 2026 event. The company showcased new tools and data sets that support advanced spatial analysis. This demonstrates progress in its product roadmap and may strengthen its position in the spatial biology market.
Quanterix Highlights Spatial Biology Innovation at ESSB 2026. Quanterix announced it met its spatial biology content innovation commitments during the ESSB 2026 event. The company showcased new tools and data sets that support advanced spatial analysis. This demonstrates progress in its product roadmap and may strengthen its position in the spatial biology market.